Sponsor or institution

Clinical trials and research at Jules Bordet Institute

• 18Clinical trials
• 11Countries

Newest trials

All recruiting trials (18)

• Immune Fitness in Older Adults with Relapsed or Refractory Multiple Myeloma

  This study checks whether immune health before treatment can predict how well older adults with relapsed or refractory multiple myeloma respond to CAR-T or bispecific antibody therapies.

  Recruiting Jules Bordet Institute · Anderlecht, Brussels Capital and 2 other locations · NCT07674498

• Biopsy and Resection Growth Patterns in Colorectal Peritoneal Cancer

  This study tests whether peritoneal growth patterns seen on small biopsies during staging laparoscopy match the patterns found in later surgical specimens for adults with colorectal peritoneal metastases.

  Recruiting Jules Bordet Institute · Brussels, Brussels Capital and 1 other locations · NCT07474025

• Ventral hernias after cytoreductive surgery: how often they occur and how they are managed.

  This retrospective review tries to find how often adults who had cytoreductive surgery with or without HIPEC develop ventral hernias and which factors are linked to them.

  Recruiting Jules Bordet Institute · Anderlecht, Brussels Capital · NCT07451483

• Lutetium-177 dosimetry to predict response to PSMA radioligand therapy in metastatic prostate cancer

  This project will test whether measuring the radiation dose delivered (dosimetry) from Lutetium-177 PSMA therapy can predict which men with metastatic prostate cancer will respond.

  Recruiting Jules Bordet Institute · Brussels · NCT07370597

• Testosterone injections to improve quality of life for men in best supportive care.

  This pilot will test whether giving Sustanon 250 testosterone injections every 15 days can improve quality of life for men with low testosterone who are receiving best supportive (palliative) care.

  Recruiting Early Phase 1 Jules Bordet Institute · Brussels · NCT07143279

• FAPI PET/MR imaging of fibroblast activity in glioblastoma

  This will try a FAPI PET/MR scan to image fibroblast activation in adults with a suspected or recurrent glioblastoma.

  Recruiting Jules Bordet Institute · Brussels · NCT07119294

• FAPI PET/CT imaging of the tumor microenvironment in colorectal cancer liver metastases

  This will try FAPI PET/CT imaging to highlight cancer-associated fibroblasts and growth patterns in adults with colorectal cancer that has spread to the liver and who are scheduled for surgical removal of their metastases.

  Recruiting Jules Bordet Institute · Brussels · NCT07109440

• Stereotactic radiotherapy for limited progression in ER+/HER2- metastatic breast cancer

  This trial will try stereotactic body radiotherapy (SBRT) to treat 1–3 new resistant extracranial metastases in women with ER+/HER2- metastatic breast cancer on endocrine therapy and/or CDK4/6 inhibitors to see if local treatment lets them stay on their current systemic therapy longer.

  Recruiting at 5 sites Jules Bordet Institute · Brussels and 4 other locations · NCT06925984

• Using PSMA PET to improve detection of significant prostate cancer lesions during MRI-targeted biopsy

  This study is testing if a special type of imaging called PSMA PET can help find important prostate cancer spots that might be missed during regular MRI-targeted biopsies in men with high-risk localized prostate cancer.

  Recruiting Jules Bordet Institute · Brussels · NCT06867588

• Radiotherapy for prostate cancer recurrence after surgery

  This study is testing if a new type of focused radiation treatment can help men whose prostate cancer has come back after surgery feel better compared to standard radiation therapy.

  Recruiting at 13 sites Jules Bordet Institute · Aalst and 12 other locations · NCT06523634

• Ketorolac and pregabalin to modify perioperative inflammation and nerve signaling in early ER+ breast cancer

  This trial will test whether giving short-term ketorolac, pregabalin, or both around surgery can blunt inflammatory and neural signals in adults having surgery for early estrogen-receptor–positive breast cancer.

  Recruiting Phase 2 Jules Bordet Institute · Brussels · NCT06150898

• Imaging cancer-associated fibroblasts in lung cancer patients receiving immunotherapy

  This study is testing whether a special imaging technique can help doctors see how certain cells in lung cancer patients respond to immunotherapy and predict their treatment outcomes.

  Recruiting Jules Bordet Institute · Brussels · NCT06107608

• Using Ga68-FAPI-46 PET/CT to assess peritoneal carcinomatosis before surgery

  This study is testing a new type of imaging scan to see if it can better detect cancer spread in the abdomen before surgery for people with colorectal and ovarian cancer.

  Recruiting Jules Bordet Institute · Brussels · NCT06061874

• Assessing PSMA in Patients with Progressive Triple-Negative Breast Cancer

  This study is testing if a special imaging technique can help find a targeted treatment for patients with advanced triple-negative breast cancer.

  Recruiting Phase 2 Jules Bordet Institute · Brussels · NCT06059469

• Comparing two treatment options for older patients with advanced rectal cancer

  This study is testing whether short course radiotherapy or total neoadjuvant therapy works better for older patients with advanced rectal cancer.

  Recruiting at 15 sites Jules Bordet Institute · Antwerp, Antwerpen and 18 other locations · NCT06052332

• A platform to study brain metastases in solid tumors

  This study is trying to find better treatments for patients with solid tumors that are likely to spread to the brain by collecting and analyzing their tumor samples and health data.

  Recruiting at 17 sites Jules Bordet Institute · Anderlecht and 16 other locations · NCT04109131

• Evaluating swallowing function and quality of life in patients with oropharyngeal cancer after treatment

  This study tests whether placing a feeding tube before or after treatment helps people with oropharyngeal cancer swallow better and improves their quality of life during chemoradiotherapy.

  Recruiting Phase 3 Jules Bordet Institute · Brussels and 1 other locations · NCT04019548

• Understanding genetic changes in metastatic breast cancer

  This study is trying to find out how genetic changes in metastatic breast cancer affect treatment responses by collecting samples from patients who have recently been diagnosed or relapsed.

  Recruiting at 10 sites Jules Bordet Institute · Brussels and 51 other locations · NCT02102165

Quick answers

How many clinical trials run by Jules Bordet Institute are recruiting right now?

18, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 11 countries. The most sites are in Belgium (18 trials), Luxembourg (2 trials), Germany (1 trial), Iceland (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 3: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →